Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

Journal of clinical medicine·2026
Same author

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

International journal of cancer·2026
Same author

Small Cemetery Within.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Two economies of medical knowledge: The publishing oligopoly and the clinical trial shadow profession.

Accountability in research·2026
Same author

Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Cost, Context, and Confounding: Rethinking Real-World data Generation and Interpretation in Advanced NSCLC.

The oncologist·2026

相关实验视频

Updated: Jun 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

259

机器学习用于预测结肠癌复发情况.

Erkan Kayikcioglu1, Arif Hakan Onder2, Burcu Bacak1

  • 1Department of Medical Oncology, Suleyman Demirel University, Isparta, Turkey.

Surgical oncology
|April 30, 2024
PubMed
概括

机器学习通过分析患者数据,准确地预测结肠癌复发. 这项技术有助于早期检测和个性化治疗,改善患者的治疗结果.

关键词:
在CatBoost分类器中,分类器是CatBoost.临床病理学因素 临床病理学因素结肠癌的复发情况机器学习是机器学习.预测模型的预测模型.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.8K

相关实验视频

Last Updated: Jun 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

259
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.8K

科学领域:

  • 在瘤学瘤学.
  • 数据科学数据科学数据科学
  • 医疗信息学 医疗信息学

背景情况:

  • 结肠直肠癌 (CRC) 是一个主要的全球健康问题,复发率很高.
  • 早期检测和干预对于控制CRC复发至关重要.
  • 机器学习 (ML) 为癌症护理中的数据驱动洞察提供了先进的工具.

研究的目的:

  • 开发和评估用于预测结肠癌 (CC) 复发的ML算法.
  • 确定与CC复发相关的主要人口,临床病理和实验室因素.
  • 为了增强个人化风险分层为CC患者.

主要方法:

  • 对396名结肠癌患者 (2010-2021) 的回顾性分析.
  • 应用ML算法来预测CC的复发.
  • 使用AUC,准确性,回忆,精度和F1分数进行评估.

主要成果:

  • 确定了重要的风险因素:性别,CEA,瘤位置/深度,入侵和淋巴结状况.
  • CatBoost 分类器实现了0.92 AUC和88%的准确性.
  • 关键预测因素包括CEA,白蛋白,N阶段,体重和血液细胞计数.

结论:

  • ML的整合使得个性化风险分层和改善了CC的临床决策.
  • 早期识别高风险患者可以导致更有效的治疗方法.
  • 这项研究强调了ML在CC管理的精密瘤学中的变革潜力.